medmix AG Statistics

Total Valuation

medmix AG has a market cap or net worth of CHF 362.61 million. The enterprise value is 595.51 million.

Market Cap	362.61M
Enterprise Value	595.51M

Important Dates

The next estimated earnings date is Wednesday, February 26, 2025.

Earnings Date	Feb 26, 2025
Ex-Dividend Date	n/a

Share Statistics

medmix AG has 40.79 million shares outstanding. The number of shares has increased by 2.48% in one year.

Current Share Class	n/a
Shares Outstanding	40.79M
Shares Change (YoY)	+2.48%
Shares Change (QoQ)	+3.54%
Owned by Insiders (%)	0.18%
Owned by Institutions (%)	28.26%
Float	23.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	14.17
PS Ratio	0.78
PB Ratio	0.79
P/TBV Ratio	n/a
P/FCF Ratio	14.92
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.16, with an EV/FCF ratio of 24.51.

EV / Earnings	-330.84
EV / Sales	1.24
EV / EBITDA	8.16
EV / EBIT	35.87
EV / FCF	24.51

Financial Position

The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.77.

Current Ratio	1.48
Quick Ratio	1.03
Debt / Equity	0.77
Debt / EBITDA	4.98
Debt / FCF	14.98
Interest Coverage	1.39

Financial Efficiency

Return on equity (ROE) is -0.21% and return on invested capital (ROIC) is 1.27%.

Return on Equity (ROE)	-0.21%
Return on Assets (ROA)	1.03%
Return on Capital (ROIC)	1.27%
Revenue Per Employee	177,996
Profits Per Employee	-668
Employee Count	2,658
Asset Turnover	0.48
Inventory Turnover	3.40

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.73% in the last 52 weeks. The beta is 0.79, so medmix AG's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-52.73%
50-Day Moving Average	9.82
200-Day Moving Average	13.27
Relative Strength Index (RSI)	32.92
Average Volume (20 Days)	47,377

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, medmix AG had revenue of CHF 479.70 million and -1.80 million in losses. Loss per share was -0.04.

Revenue	479.70M
Gross Profit	156.30M
Operating Income	16.60M
Pretax Income	500,000
Net Income	-1.80M
EBITDA	63.50M
EBIT	16.60M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 140.70 million in cash and 363.90 million in debt, giving a net cash position of -223.20 million or -5.47 per share.

Cash & Cash Equivalents	140.70M
Total Debt	363.90M
Net Cash	-223.20M
Net Cash Per Share	-5.47
Equity (Book Value)	470.50M
Book Value Per Share	11.30
Working Capital	105.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 69.30 million and capital expenditures -45.00 million, giving a free cash flow of 24.30 million.

Operating Cash Flow	69.30M
Capital Expenditures	-45.00M
Free Cash Flow	24.30M
FCF Per Share	0.60

Full Cash Flow Statement

Margins

Gross margin is 32.58%, with operating and profit margins of 3.46% and -0.38%.

Gross Margin	32.58%
Operating Margin	3.46%
Pretax Margin	0.10%
Profit Margin	-0.38%
EBITDA Margin	13.24%
EBIT Margin	3.46%
FCF Margin	5.07%

Dividends & Yields

This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 5.51%.

Dividend Per Share	0.50
Dividend Yield	5.51%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.48%
Shareholder Yield	3.03%
Earnings Yield	-0.48%
FCF Yield	6.70%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

medmix AG has an Altman Z-Score of 2.16. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.16
Piotroski F-Score	n/a